Potential mechanisms of resistance to cytarabine in AML patients
- 18 December 2001
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 26 (7) , 621-629
- https://doi.org/10.1016/s0145-2126(01)00184-9
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Five putative drug resistance parameters (MDR1/P‐glycoprotein, MDR‐associated protein, glutathione‐S‐transferase, bcl‐2 and topoisomerase IIα) in 57 newly diagnosed acute myeloid leukaemiasEuropean Journal of Haematology, 1997
- A possible role for topoisomerase II in cell death and N-phosphonoacetyl-l-aspartate-resistance frequency and its enhancement by 1-β-d-arabinofuranosyl cytosine and 5-fluoro-2′-deoxyuridineMutation Research/DNA Repair, 1997
- Mammalian deoxyribonucleoside kinasesPharmacology & Therapeutics, 1995
- Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patientsBritish Journal of Haematology, 1994
- Hypoxanthine‐guanine phosphoribosyl‐transferase in childhood leukemia: Relation with immunophenotype, in vitro drug resistance and clinical prognosisInternational Journal of Cancer, 1992
- The role of 5′nucleotidase in therapy-resistance of childhood leukemiaMedical Hypotheses, 1988
- Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.Journal of Clinical Investigation, 1985
- Prognostic value of 5′nucleotidase in acute lymphoblastic leukemia with the common-all phenotypeLeukemia Research, 1985
- Effect of ara-C incorporation on deoxyribonucleic acid synthesis in cellsBiochemical Pharmacology, 1982
- Mechanisms of Resistance of Human Acute Leukaemia Cells to Cytosine ArabinosideBritish Journal of Haematology, 1974